Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ischemic colitis during interferon-alpha treatment for chronic active hepatitis C

H Tada1, S Saitoh, Y Nakagawa

  • 1Division of Gastroenterology, Hoshigaoka Koseinenkin Hospital, Osaka, Japan.

Journal of Gastroenterology
|August 1, 1996
PubMed
Summary

Interferon (IFN) treatment for chronic hepatitis C can cause ischemic colitis, a rare but serious complication. This condition, characterized by colon ulcerations, resolved after discontinuing IFN therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identifying prognostic biomarkers for palbociclib add-on therapy in fulvestrant-resistant breast cancer using cell-free DNA sequencing.

ESMO open·2024
Same author

Improved Measurements of Muonic Helium Ground-State Hyperfine Structure at a Near-Zero Magnetic Field.

Physical review letters·2024
Same author

Comprehensive validation of early diagnostic algorithms for myocardial infarction in the emergency department.

QJM : monthly journal of the Association of Physicians·2023
Same author

Assessment of transporter-mediated efflux of nintedanib using <i>in vitro</i> cell line models of idiopathic pulmonary fibrosis.

Die Pharmazie·2020
Same author

<sup>18</sup>F-fluorodeoxyglucose specimen-positron emission mammography delineates tumour extension in breast-conserving surgery: Preliminary results.

European radiology·2017
Same author

A distinct function of the retinoblastoma protein in the control of lipid composition identified by lipidomic profiling.

Oncogenesis·2017

Area of Science:

  • Gastroenterology
  • Hepatology
  • Internal Medicine

Background:

  • Chronic hepatitis C is a significant global health concern.
  • Interferon (IFN) therapy has been a primary treatment for chronic hepatitis C.
  • Monitoring for adverse events during IFN treatment is crucial.

Observation:

  • Two cases of ischemic colitis were observed in 280 patients treated with interferon-alpha for chronic hepatitis C.
  • Symptoms included melena, appearing in the second and sixth months of treatment.
  • Colonoscopies revealed longitudinal ulcerations in the descending colon.

Findings:

  • Ischemic colitis occurred in 0.7% of patients receiving interferon treatment.
  • Ulcerations resolved within two weeks of discontinuing interferon therapy.

Related Experiment Videos

  • A potential association between interferon treatment and ischemic colitis is suggested.

    • Implications:

    • Healthcare providers should be aware of ischemic colitis as a potential complication of interferon therapy for hepatitis C.
    • Early recognition and discontinuation of interferon may lead to resolution of ischemic colitis.
    • Further research into the mechanisms and risk factors for IFN-induced ischemic colitis is warranted.